Efficacy, safety and pharmacokinetics of indacaterol in Caucasian and Japanese patients with chronic obstructive pulmonary disease: a comparison of data from two randomized, placebo-controlled studies.
about
Single- and multiple-dose pharmacokinetics of inhaled indacaterol in healthy Chinese volunteers.Chronic obstructive pulmonary disease in China: the potential role of indacaterolThe efficacy and safety of combined tiotropium and olodaterol via the Respimat(®) inhaler in patients with COPD: results from the Japanese sub-population of the Tonado(®) studiesIndacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease.Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation.Emerging inhaled long-acting beta-2 adrenoceptor agonists for the treatment of COPD.
P2860
Efficacy, safety and pharmacokinetics of indacaterol in Caucasian and Japanese patients with chronic obstructive pulmonary disease: a comparison of data from two randomized, placebo-controlled studies.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Efficacy, safety and pharmacok ...... d, placebo-controlled studies.
@ast
Efficacy, safety and pharmacok ...... d, placebo-controlled studies.
@en
type
label
Efficacy, safety and pharmacok ...... d, placebo-controlled studies.
@ast
Efficacy, safety and pharmacok ...... d, placebo-controlled studies.
@en
prefLabel
Efficacy, safety and pharmacok ...... d, placebo-controlled studies.
@ast
Efficacy, safety and pharmacok ...... d, placebo-controlled studies.
@en
P2093
P2860
P1476
Efficacy, safety and pharmacok ...... d, placebo-controlled studies.
@en
P2093
Benjamin Kramer
David Lawrence
Motoi Hosoe
Ralph Woessner
Soichiro Matsushima
P2860
P304
P356
10.2165/11586520-000000000-00000
P577
2011-01-01T00:00:00Z